Efficacy and Safety of EsoDuo® — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of EsoDuo® — Stella

Home/Gastro Esophageal Reflux/

View on ClinicalTrials.gov

Recruiting

Back to Gastro Esophageal Reflux trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

South Korea

Asan Medical Center, Seoul

Key details

Phase

Post-approval study

Sponsor

Chong Kun Dang Pharmaceutical

Enrollment target

~180 participants

Started

November 2022

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.